These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12380231)

  • 1. Immunogenicity and efficacy of Fermi-type nerve tissue rabies vaccine in mice and in humans undergoing post-exposure prophylaxis for rabies in Ethiopia.
    Ayele W; Fekadu M; Zewdie B; Beyene M; Bogale Y; Mocha K; Egziabher FG
    Ethiop Med J; 2001 Oct; 39(4):313-21. PubMed ID: 12380231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of determination of rabies virus neutralizing antibody titres in the sera of vaccinated humans.].
    Butirskiy AY; Muhacheva AV; Movsesyants AA; Sarkisyan KA
    Vopr Virusol; 2019; 64(6):298-305. PubMed ID: 32168444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines.
    Quiambao BP; Lang J; Vital S; Montalban CG; Le Mener V; Wood SC; Miranda E
    Acta Trop; 2000 Feb; 75(1):39-52. PubMed ID: 10708006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India.
    Matha IS; Salunke SR
    Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short duration of neutralizing antibody titers after pre-exposure rabies vaccination with suckling mouse brain vaccine.
    Zanetti CR; Consales CA; Rodrigues-da-Silva AC; Toyoshima YK; Pereira OA
    Braz J Med Biol Res; 1998 Oct; 31(10):1275-80. PubMed ID: 9876298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children.
    Janewongwirot P; Jantarabenjakul W; Anugulruengkitt S; Anunsittichai O; Saengseesom W; Buranapraditkun S; Sophonphan J; Wacharachaisurapol N; Jitrungruengnij N; Pancharoen C; Puthanakit T
    Vaccine; 2019 Aug; 37(36):5307-5313. PubMed ID: 31358408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
    Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
    Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population.
    Sehgal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroconversion following incomplete human rabies postexposure prophylaxis.
    Robertson K; Recuenco S; Niezgoda M; Garcia EJ; Rupprecht CE
    Vaccine; 2010 Sep; 28(39):6523-6. PubMed ID: 20637309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a booster-dose of rabies vaccine on the duration of virus neutralizing antibody titers in bovines.
    Albas A; Pardo PE; Gomes AA; Bernardi F; Ito FH
    Rev Soc Bras Med Trop; 1998; 31(4):367-71. PubMed ID: 9662964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.
    Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V
    Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.
    Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V
    Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.